BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7475313)

  • 1. Stem cell stimulation in vitro by the dekapeptide (pEEDCK)2: a single-factor alternative for multifactor cocktails.
    Paukovits JB; Paukovits WR
    Leukemia; 1995 Oct; 9 Suppl 1():S48-52. PubMed ID: 7475313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
    Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
    Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to the stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation.
    Paukovits WR; Paukovits JB; Moser MH; Konstantinov S; Schulte-Hermann R
    Exp Hematol; 1998 Aug; 26(9):851-8. PubMed ID: 9694506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hemoregulatory peptide pEEDCK may inhibit stem cell proliferation via hydropathic binding to antisense sequence motifs in interleukin-11 and other growth factors.
    Paukovits JB; Rutter R; Ganglberger E; Karlic HI; Marian B; Paukovits WR
    Mol Pharmacol; 1999 Oct; 56(4):665-74. PubMed ID: 10496948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys: a new synthetic derivative for avoiding dimerization and loss of inhibitory activity.
    Paukovits WR; Hergl A; Schulte-Hermann R
    Mol Pharmacol; 1990 Sep; 38(3):401-9. PubMed ID: 2402229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
    Güenechea G; Bueren JA; Maganto G; Tuduri P; Guerrero A; Pivel JP; Real A
    Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
    Jackson JD; Yan Y; Ewel C; Talmadge JE
    Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay.
    Breems DA; Blokland EA; Neben S; Ploemacher RE
    Leukemia; 1994 Jul; 8(7):1095-104. PubMed ID: 8035601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Culture and characterization of hematopoietic progenitor cells from miniature swine.
    Emery DW; Sachs DH; LeGuern C
    Exp Hematol; 1996 Jul; 24(8):927-35. PubMed ID: 8690052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced myelopoiesis in long-term cultures of human bone marrow pretreated with recombinant granulocyte-macrophage colony-stimulating factor.
    Haas R; Ogniben E; Kiesel S; Hohaus S; Baumann M; Körbling M; Dörken B; Hunstein W
    Exp Hematol; 1989 Mar; 17(3):235-9. PubMed ID: 2645156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
    Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
    Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IL-6 antibodies suppress myeloid cell production and the generation of CFU-c in long-term bone marrow cultures.
    Hudak S; Thompson-Snipes L; Rocco C; Jackson J; Pearce M; Rennick D
    Exp Hematol; 1992 May; 20(4):412-7. PubMed ID: 1373686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of colony-stimulating activity production from bone marrow stromal cells by the hematoregulatory peptide, HP-5.
    King AG; Talmadge JE; Badger AM; Pelus LM
    Exp Hematol; 1992 Feb; 20(2):223-8. PubMed ID: 1544391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-inhibitory effect of 2-CdA on myeloid CFU-GM progenitors in normal human long-term bone marrow cultures and its compensation by G-CSF or IL-3.
    Petzer AL; Geisen FH; Bilgeri R; Zilian U; Haun M; Herold M; Braunsteiner H; Konwalinka G
    Exp Hematol; 1995 Jun; 23(6):529-34. PubMed ID: 7539380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of haemoregulatory peptides (pEEDCK monomer and dimer) for reduction of cytostatic drug induced haemopoietic damage.
    Paukovits WR; Moser MH; Binder KA; Paukovits JB
    Cancer Treat Rev; 1990 Sep; 17(2-3):347-54. PubMed ID: 2272050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
    Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
    Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherent-cell-dependent stimulation of CFU-GM by nucleobases, nucleosides, their analogues, and the hemoregulatory peptide dimer.
    Langen P; Schunck H; Hunger B; Schütt M; Laerum OD
    Exp Hematol; 1992 Feb; 20(2):196-200. PubMed ID: 1544389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
    Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
    Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.